Personal information

Other IDs

Scopus Author ID: 7003854085
ResearcherID: K-8753-2016

Activities

Collapse all

Employment (1)

Fondazione IRCCS Istituto Nazionale dei Tumori: Milano, Lombardia, IT

Employment
Source: Self-asserted source
Mariangela Figini

Works (50 of 73)

Items per page:
Page 1 of 2

Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial

Nature Communications
2023-07-25 | Journal article
DOI: 10.1038/s41467-023-39679-9
Contributors: James Spicer; Bristi Basu; Ana Montes; Udai Banerji; Rebecca Kristeleit; Rowan Miller; Gareth J. Veal; Christopher J. Corrigan; Stephen J. Till; Mariangela Figini et al.
Source: check_circle
Crossref

COVID-19 Vaccination in Health Care Workers in Italy: A Literature Review and a Report from a Comprehensive Cancer Center

Vaccines
2022-05-07 | Journal article
DOI: 10.3390/vaccines10050734
Contributors: Chiara Maura Ciniselli; Mara Lecchi; Mariangela Figini; Cecilia C. Melani; Maria Grazia Daidone; Daniele Morelli; Emanuela Zito; Giovanni Apolone; Paolo Verderio
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Choline kinase alpha impairment overcomes TRAIL resistance in ovarian cancer cells

Journal of Experimental and Clinical Cancer Research
2021 | Journal article
DOI: 10.1186/s13046-020-01794-6
EID:

2-s2.0-85098561399

Part of ISSN: 17569966
Contributors: Rizzo, A.; Satta, A.; Garrone, G.; Cavalleri, A.; Napoli, A.; Raspagliesi, F.; Figini, M.; De Cecco, L.; Iorio, E.; Tomassetti, A. et al.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

Validity of Anti-PSMA ScFvD2B as a Theranostic Tool: A Narrative-Focused Review

Biomedicines
2021-12-10 | Journal article
DOI: 10.3390/biomedicines9121870
Contributors: Barbara Frigerio; Elena Luison; Alessandro Desideri; Federico Iacovelli; Chiara Camisaschi; Ettore C. Seregni; Silvana Canevari; Mariangela Figini
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Macrophages Impair TLR9 Agonist Antitumor Activity through Interacting with the Anti-PD-1 Antibody Fc Domain

Cancers
2021-08-13 | Journal article
DOI: 10.3390/cancers13164081
Contributors: Simone Camelliti; Valentino Le Noci; Francesca Bianchi; Chiara Storti; Francesca Arnaboldi; Alessandra Cataldo; Serena Indino; Elena Jachetti; Mariangela Figini; Mario Paolo Colombo et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

SARS-CoV-2 Serology Monitoring of a Cancer Center Staff in the Pandemic Most Infected Italian Region

Cancers
2021-03 | Journal article | Author
DOI: 10.3390/cancers13051035
Contributors: Chiara Maura Ciniselli; Arianna Micali; loris de cecco; Paola Notti; Valentina Sinno; Elena Luison; Cecilia C. Melani; Maria Grazia Daidone; Giovanni Apolone; Paolo Verderio et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Enhancing ovarian cancer conventional chemotherapy through the combination with cannabidiol loaded microparticles

European Journal of Pharmaceutics and Biopharmaceutics
2020 | Journal article
DOI: 10.1016/j.ejpb.2020.07.008
EID:

2-s2.0-85088667815

Part of ISSN: 18733441 09396411
Contributors: Fraguas-Sánchez, A.I.; Fernández-Carballido, A.; Delie, F.; Cohen, M.; Martin-Sabroso, C.; Mezzanzanica, D.; Figini, M.; Satta, A.; Torres-Suárez, A.I.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

Rapid conjugation of antibodies to toxins to select candidates for the development of anticancer Antibody-Drug Conjugates (ADCs)

Scientific Reports
2020 | Journal article
DOI: 10.1038/s41598-020-65860-x
EID:

2-s2.0-85085876418

Part of ISSN: 20452322
Contributors: Hoffmann, R.M.; Mele, S.; Cheung, A.; Larcombe-Young, D.; Bucaite, G.; Sachouli, E.; Zlatareva, I.; Morad, H.O.J.; Marlow, R.; McDonnell, J.M. et al.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

Selinexor Sensitizes TRAIL-R2-Positive TNBC Cells to the Activity of TRAIL-R2xCD3 Bispecific Antibody

Cells
2020 | Journal article
DOI: 10.3390/cells9102231
EID:

2-s2.0-85092654527

Part of ISSN: 20734409
Contributors: Martini, S.; Figini, M.; Croce, A.; Frigerio, B.; Pennati, M.; Gianni, A.M.; De Marco, C.; Daidone, M.G.; Argueta, C.; Landesman, Y. et al.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

IgE Activates Monocytes from Cancer Patients to Acquire a Pro-Inflammatory Phenotype

Cancers
2020-11 | Journal article | Author
DOI: 10.3390/cancers12113376
Contributors: Mano Nakamura; Elmira Amiri Souri; Gabriel Osborn; Roman Laddach; Jitesh Chauhan; Chara Stavraka; Sara Lombardi; Anna Black; Atousa Khiabany; Duaa O. Khair et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Development of 177Lu-scFvD2B as a Potential Immunotheranostic Agent for Tumors Overexpressing the Prostate Specific Membrane Antigen

Scientific Reports
2020-06-09 | Journal article
DOI: 10.1038/s41598-020-66285-2
Contributors: Debora Carpanese; Guillermina Ferro-Flores; Blanca Ocampo-Garcia; Clara Santos-Cuevas; Nicola Salvarese; Mariangela Figini; Giulio Fracasso; Laura De Nardo; Cristina Bolzati; Antonio Rosato et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

A bispecific antibody to link a trail-based antitumor approach to immunotherapy

Frontiers in Immunology
2019 | Journal article
DOI: 10.3389/fimmu.2019.02514
EID:

2-s2.0-85074609352

Part of ISSN: 16643224
Contributors: Satta, A.; Grazia, G.; Caroli, F.; Frigerio, B.; Di Nicola, M.; Raspagliesi, F.; Mezzanzanica, D.; Zaffaroni, N.; Gianni, A.M.; Anichini, A. et al.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

Anti-PSMA <sup>124</sup>I-scFvD2B as a new immuno-PET tool for prostate cancer: Preclinical proof of principle

Journal of Experimental and Clinical Cancer Research
2019 | Journal article
DOI: 10.1186/s13046-019-1325-6
EID:

2-s2.0-85069794581

Part of ISSN: 17569966
Contributors: Frigerio, B.; Morlino, S.; Luison, E.; Seregni, E.; Lorenzoni, A.; Satta, A.; Valdagni, R.; Bogni, A.; Chiesa, C.; Mira, M. et al.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

Folate receptors and transporters: Biological role and diagnostic/therapeutic targets in cancer and other diseases

Journal of Experimental and Clinical Cancer Research
2019 | Journal article
DOI: 10.1186/s13046-019-1123-1
EID:

2-s2.0-85062826744

Part of ISSN: 17569966
Contributors: Frigerio, B.; Bizzoni, C.; Jansen, G.; Leamon, C.P.; Peters, G.J.; Low, P.S.; Matherly, L.H.; Figini, M.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

An immunologically relevant rodent model demonstrates safety of therapy using a tumour-specific IgE

Allergy: European Journal of Allergy and Clinical Immunology
2018 | Journal article
DOI: 10.1111/all.13455
EID:

2-s2.0-85054591933

Part of ISSN: 13989995 01054538
Contributors: Josephs, D.H.; Nakamura, M.; Bax, H.J.; Dodev, T.S.; Muirhead, G.; Saul, L.; Karagiannis, P.; Ilieva, K.M.; Crescioli, S.; Gazinska, P. et al.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

Anti-folate receptor alpha-directed antibody therapies restrict the growth of triple-negative breast cancer

Clinical Cancer Research
2018 | Journal article
DOI: 10.1158/1078-0432.CCR-18-0652
EID:

2-s2.0-85054889950

Part of ISSN: 15573265 10780432
Contributors: Cheung, A.; Opzoomer, J.; Ilieva, K.M.; Gazinska, P.; Hoffmann, R.M.; Mirza, H.; Marlow, R.; Francesch-Domenech, E.; Fittall, M.; Dominguez Rodriguez, D. et al.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

Design, selection and optimization of an anti-TRAIL-R2/anti-CD3 bispecific antibody able to educate T cells to recognize and destroy cancer cells

mAbs
2018 | Journal article
DOI: 10.1080/19420862.2018.1494105
EID:

2-s2.0-85052629638

Part of ISSN: 19420870 19420862
Contributors: Satta, A.; Mezzanzanica, D.; Caroli, F.; Frigerio, B.; Di Nicola, M.; Kontermann, R.E.; Iacovelli, F.; Desideri, A.; Anichini, A.; Canevari, S. et al.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

Evaluation of antigen-conjugated fluorescent beads to identify antigen-specific B cells

Frontiers in Immunology
2018 | Journal article
DOI: 10.3389/fimmu.2018.00493
EID:

2-s2.0-85044451729

Part of ISSN: 16643224
Contributors: Correa, I.; Ilieva, K.M.; Crescioli, S.; Lombardi, S.; Figini, M.; Cheung, A.; Spicer, J.F.; Tutt, A.N.J.; Nestle, F.O.; Karagiannis, P. et al.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

Selective targeting and degradation of doxorubicin-loaded folate-functionalized DNA nanocages

Nanomedicine: Nanotechnology, Biology, and Medicine
2018 | Journal article
DOI: 10.1016/j.nano.2018.02.002
EID:

2-s2.0-85044614763

Part of ISSN: 15499642 15499634
Contributors: Raniolo, S.; Vindigni, G.; Ottaviani, A.; Unida, V.; Iacovelli, F.; Manetto, A.; Figini, M.; Stella, L.; Desideri, A.; Biocca, S.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

Anti-folate receptor-α IgE but not IgG recruits macrophages to attack tumors via TNFa/MCP-1 signaling

Cancer Research
2017 | Journal article
DOI: 10.1158/0008-5472.CAN-16-1829
EID:

2-s2.0-85015827591

Part of ISSN: 15387445 00085472
Contributors: Josephs, D.H.; Bax, H.J.; Dodev, T.; Georgouli, M.; Nakamura, M.; Pellizzari, G.; Saul, L.; Karagiannis, P.; Cheung, A.; Herraiz, C. et al.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

Full preclinical validation of the <sup>123</sup>I-labeled anti-PSMA antibody fragment ScFvD2B for prostate cancer imaging

Oncotarget
2017 | Journal article
DOI: 10.18632/oncotarget.14229
EID:

2-s2.0-85012892207

Part of ISSN: 19492553
Contributors: Frigerio, B.; Franssen, G.; Luison, E.; Satta, A.; Seregni, E.; Colombatti, M.; Fracasso, G.; Valdagni, R.; Mezzanzanica, D.; Boerman, O. et al.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

Functionally active Fc mutant antibodies recognizing cancer antigens generated rapidly at high yields

Frontiers in Immunology
2017 | Journal article
DOI: 10.3389/fimmu.2017.01112
EID:

2-s2.0-85029216942

Part of ISSN: 16643224
Contributors: Ilieva, K.M.; Fazekas-Singer, J.; Achkova, D.Y.; Dodev, T.S.; Mele, S.; Crescioli, S.; Bax, H.J.; Cheung, A.; Karagiannis, P.; Correa, I. et al.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

Functionally active Fc Mutant antibodies recognizing cancer antigens generated rapidly at high Yields

Frontiers in Immunology
2017 | Journal article
DOI: 10.3389/fimmu.2017.01122
EID:

2-s2.0-85029219626

Part of ISSN: 16643224
Contributors: Ilieva, K.M.; Fazekas-Singer, J.; Achkova, D.Y.; Dodev, T.S.; Mele, S.; Crescioli, S.; Bax, H.J.; Cheung, A.; Karagiannis, P.; Correa, I. et al.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

Effective adoptive immunotherapy of triple-negative breast cancer by folate receptor-alpha redirected CAR T cells is influenced by surface antigen expression level

Journal of Hematology and Oncology
2016 | Journal article
DOI: 10.1186/s13045-016-0285-y
EID:

2-s2.0-84979225446

Part of ISSN: 17568722
Contributors: Song, D.-G.; Ye, Q.; Poussin, M.; Chacon, J.A.; Figini, M.; Powell, D.J.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

In vivo imaging of prostate cancer using an anti-PSMA scFv fragment as a probe

Scientific Reports
2016 | Journal article
DOI: 10.1038/srep23314
EID:

2-s2.0-84961782254
Contributors: Mazzocco, C.; Fracasso, G.; Germain-Genevois, C.; Dugot-Senant, N.; Figini, M.; Colombatti, M.; Grenier, N.; Couillaud, F.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

Targeting folate receptor alpha for cancer treatment

Oncotarget
2016 | Journal article
DOI: 10.18632/oncotarget.9651
EID:

2-s2.0-84982261489

Part of ISSN: 19492553
Contributors: Cheung, A.; Bax, H.J.; Josephs, D.H.; Ilieva, K.M.; Pellizzari, G.; Opzoomer, J.; Bloomfield, J.; Fittall, M.; Grigoriadis, A.; Figini, M. et al.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

“Cancer Bio-Immunotherapy in Siena”: Thirteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 8–10, 2015

Cancer Immunology, Immunotherapy
2016 | Journal article
DOI: 10.1007/s00262-016-1899-1
EID:

2-s2.0-84987625526

Part of ISSN: 14320851 03407004
Contributors: Maio, M.; Bertocci, E.; Fazio, C.; Chiarucci, C.; Cutaia, O.; Scala, E.; Giacobini, G.; Lofiego, M.F.; Fonsatti, E.; Maccalli, C. et al.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

A fully human chimeric antigen receptor with potent activity against cancer cells but reduced risk for off-tumor toxicity

Oncotarget
2015 | Journal article
EID:

2-s2.0-84940742884
Contributors: Song, D.-G.; Ye, Q.; Poussin, M.; Liu, L.; Figini, M.; Powell, D.J.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

Computational design of novel peptidomimetic inhibitors of cadherin homophilic interactions

Organic and Biomolecular Chemistry
2015 | Journal article
DOI: 10.1039/c4ob02538e
EID:

2-s2.0-84923377736
Contributors: Doro, F.; Colombo, C.; Alberti, C.; Arosio, D.; Belvisi, L.; Casagrande, C.; Fanelli, R.; Manzoni, L.; Parisini, E.; Piarulli, U. et al.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

Effect of radiochemical modification on biodistribution of scFvD2B antibody fragment recognising prostate specific membrane antigen

Immunology Letters
2015 | Journal article
DOI: 10.1016/j.imlet.2015.09.012
EID:

2-s2.0-84943631843
Contributors: Frigerio, B.; Benigni, F.; Luison, E.; Seregni, E.; Pascali, C.; Fracasso, G.; Morlino, S.; Valdagni, R.; Mezzanzanica, D.; Canevari, S. et al.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

Rigorous optimization and validation of potent RNA CAR T cell therapy for the treatment of common epithelial cancers expressing folate receptor

Oncotarget
2015 | Journal article
DOI: 10.18632/oncotarget.5029
EID:

2-s2.0-84945157569
Contributors: Schutsky, K.; Song, D.-G.; Lynn, R.; Smith, J.B.; Poussin, M.; Figini, M.; Zhao, Y.; Powell, D.J.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

Targeting FR-expressing cells in ovarian cancer with Fab-functionalized nanoparticles: A full study to provide the proof of principle from in vitro to in vivo

Nanoscale
2015 | Journal article
DOI: 10.1039/c4nr04426f
EID:

2-s2.0-84922365495
Contributors: Quarta, A.; Bernareggi, D.; Benigni, F.; Luison, E.; Nano, G.; Nitti, S.; Cesta, M.C.; Di Ciccio, L.; Canevari, S.; Pellegrino, T. et al.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

PSMA-Specific CAR-Engineered T Cells Eradicate Disseminated Prostate Cancer in Preclinical Models

PLoS ONE
2014 | Journal article
DOI: 10.1371/journal.pone.0109427
EID:

2-s2.0-84937765737
Contributors: Zuccolotto, G.; Fracasso, G.; Merlo, A.; Montagner, I.M.; Rondina, M.; Bobisse, S.; Figini, M.; Cingarlini, S.; Colombatti, M.; Zanovello, P. et al.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

A single-chain fragment against prostate specific membrane antigen as a tool to build theranostic reagents for prostate cancer

European Journal of Cancer
2013 | Journal article
DOI: 10.1016/j.ejca.2013.01.024
EID:

2-s2.0-84877711673
Contributors: Frigerio, B.; Fracasso, G.; Luison, E.; Cingarlini, S.; Mortarino, M.; Coliva, A.; Seregni, E.; Bombardieri, E.; Zuccolotto, G.; Rosato, A. et al.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

Introductory Remarks for the Diagnostic and Therapeutic Applications of Monoclonal Antibodies and Various Formats

Autoantibodies: Third Edition
2013 | Book
DOI: 10.1016/B978-0-444-56378-1.00010-1
EID:

2-s2.0-84902057887
Contributors: Bernareggi, D.; Canevari, S.; Figini, M.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

Redirection of T-cell effector functions for cancer therapy: Bispecific antibodies and chimeric antigen receptors

Future Oncology
2013 | Journal article
DOI: 10.2217/fon.12.203
EID:

2-s2.0-84875955851
Contributors: Satta, A.; Mezzanzanica, D.; Turatti, F.; Canevari, S.; Figini, M.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

CD27 costimulation augments the survival and antitumor activity of redirected human T cells in vivo

Blood
2012 | Journal article
DOI: 10.1182/blood-2011-03-344275
EID:

2-s2.0-84856071702
Contributors: Song, D.-G.; Ye, Q.; Poussin, M.; Harms, G.M.; Figini, M.; Powell Jr., D.J.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

Antitumor effects of a human dimeric antibody fragment <sup>131</sup>I- AFRA-DFM5.3 in a mouse model for ovarian cancer

Journal of Nuclear Medicine
2011 | Journal article
DOI: 10.2967/jnumed.110.086819
EID:

2-s2.0-83755168279
Contributors: Zacchetti, A.; Martin, F.; Luison, E.; Coliva, A.; Bombardieri, E.; Allegretti, M.; Figini, M.; Canevari, S.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

Broad-spectrum inhibition of HIV-1 by a monoclonal antibody directed against a gp120-induced epitope of CD4

PLoS ONE
2011 | Journal article
DOI: 10.1371/journal.pone.0022081
EID:

2-s2.0-79960455651
Contributors: Burastero, S.E.; Frigerio, B.; Lopalco, L.; Sironi, F.; Breda, D.; Longhi, R.; Scarlatti, G.; Canevari, S.; Figini, M.; Lusso, P.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

Harnessing engineered antibodies of the IgE class to combat malignancy: Initial assessment of Fce{open}RI-mediated basophil activation by a tumour-specific IgE antibody to evaluate the risk of type I hypersensitivity

Clinical and Experimental Allergy
2011 | Journal article
DOI: 10.1111/j.1365-2222.2011.03770.x
EID:

2-s2.0-80052966648
Contributors: Rudman, S.M.; Josephs, D.H.; Cambrook, H.; Karagiannis, P.; Gilbert, A.E.; Dodev, T.; Hunt, J.; Koers, A.; Montes, A.; Taams, L. et al.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

In vivo persistence, tumor localization, and antitumor activity of CAR-engineered T cells is enhanced by costimulatory signaling through CD137 (4-1BB)

Cancer Research
2011 | Journal article
DOI: 10.1158/0008-5472.CAN-11-0422
EID:

2-s2.0-79959914449
Contributors: Song, D.-G.; Ye, Q.; Carpenito, C.; Poussin, M.; Wang, L.-P.; Ji, C.; Figini, M.; June, C.H.; Coukos, G.; Powell Jr., D.J.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

Shed HER2 extracellular domain in HER2-mediated tumor growth and in trastuzumab susceptibility

Journal of Cellular Physiology
2010 | Journal article
DOI: 10.1002/jcp.22257
EID:

2-s2.0-77956548639
Contributors: Ghedini, G.C.; Ciravolo, V.; Tortoreto, M.; Giuffrè, S.; Bianchi, F.; Campiglio, M.; Mortarino, M.; Figini, M.; Coliva, A.; Carcangiu, M.L. et al.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

<sup>177</sup>Lu- labeled MOv18 as compared to <sup>131</sup>I- or <sup>90</sup>Y-labeled MOv18 has the better therapeutic effect in eradication of alpha folate receptor-expressing tumor xenografts

Nuclear Medicine and Biology
2009 | Journal article
DOI: 10.1016/j.nucmedbio.2009.05.004
EID:

2-s2.0-69249203546
Contributors: Zacchetti, A.; Coliva, A.; Luison, E.; Seregni, E.; Bombardieri, E.; Giussani, A.; Figini, M.; Canevari, S.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

Conversion of murine antibodies to human antibodies and their optimization for ovarian cancer therapy targeted to the folate receptor

Cancer Immunology, Immunotherapy
2009 | Journal article
DOI: 10.1007/s00262-008-0575-5
EID:

2-s2.0-59449084792
Contributors: Figini, M.; Martin, F.; Ferri, R.; Luison, E.; Ripamonti, E.; Zacchetti, A.; Mortarino, M.; Di Cioccio, V.; Maurizi, G.; Allegretti, M. et al.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

Protective versus pathogenic anti-CD4 immunity: Insights from the study of natural resistance to HIV infection

Journal of Translational Medicine
2009 | Journal article
DOI: 10.1186/1479-5876-7-101
EID:

2-s2.0-71949116318
Contributors: Burastero, S.E.; Figini, M.; Frigerio, B.; Lusso, P.; Mollica, L.; Lopalco, L.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression

Clinical Cancer Research
2008 | Journal article
DOI: 10.1158/1078-0432.CCR-08-0870
EID:

2-s2.0-58149348622
Contributors: Castellano, G.; Malaponte, G.; Mazzarino, M.C.; Figini, M.; Marchese, F.; Gangemi, P.; Travali, S.; Stivala, F.; Canevari, S.; Libra, M.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

Dissecting the structural determinants of the interaction between the human cytomegalovirus UL18 protein and the CD85j immune receptor

Journal of Immunology
2008 | Journal article
EID:

2-s2.0-40449096658
Contributors: Occhino, M.; Ghiotto, F.; Soro, S.; Mortarino, M.; Bosi, S.; Maffei, M.; Bruno, S.; Nardini, M.; Figini, M.; Tramontano, A. et al.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

Redirected activity of human antitumor chimeric immune receptors is governed by antigen and receptor expression levels and affinity of interaction

Journal of Immunotherapy
2007 | Journal article
DOI: 10.1097/CJI.0b013e3180de5d90
EID:

2-s2.0-34748881184
Contributors: Turatti, F.; Figini, M.; Balladore, E.; Alberti, P.; Casalini, P.; Marks, J.D.; Canevari, S.; Mezzanzanica, D.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

Complement activated by chimeric anti-folate receptor antibodies is an efficient effector system to control ovarian carcinoma

Cancer Research
2006 | Journal article
DOI: 10.1158/0008-5472.CAN-05-3434
EID:

2-s2.0-33645741992
Contributors: Macor, P.; Mezzanzanica, D.; Cossetti, C.; Alberti, P.; Figini, M.; Canevari, S.; Tedesco, F.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier

The use of a tropism-modified measles virus in folate receptor-targeted virotherapy of ovarian cancer

Clinical Cancer Research
2006 | Journal article
DOI: 10.1158/1078-0432.CCR-06-0992
EID:

2-s2.0-33750700474
Contributors: Hasegawa, K.; Nakamura, T.; Harvey, M.; Ikeda, Y.; Oberg, A.; Figini, M.; Canevari, S.; Hartmann, L.C.; Peng, K.-W.
Source: Self-asserted source
Mariangela Figini via Scopus - Elsevier
Items per page:
Page 1 of 2

Peer review (5 reviews for 4 publications/grants)

Review activity for Biomedicine & pharmacotherapy. (2)
Review activity for Current medical science. (1)
Review activity for Journal of experimental & clinical cancer research. (1)
Review activity for Molecular diagnosis & therapy. (1)
How many people are using ORCID?